How to Choose Among Carotid Embolic Protection Devices?

Similar documents
We Catch. What Others Miss

Issam D. Moussa, MD. Professor of Medicine Mayo Clinic College of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, FL

Carotid Artery Stenting

Filters versus Occlusion Balloons during CAS Is there a clear preference?

CAROTID ARTERY ANGIOPLASTY

My Indications are based on anatomy

Nitinol biomedical devices: Design analysis

Carotid Artery Stent: Is it ready for prime time?

Why I m afraid of occlusive devices

Issues in Emerging Health Technologies

Techniques for Carotid Interventon

Two major randomised trials concerning the surgical treatment of carotid artery stenosis

CAROTID ANGIOPLASTY AND STENTING UNDER PROTECTION IS BECOMING THE GOLD STANDARD TREATMENT IN HIGH AND LOW RISK PATIENTS

Technique Of Carotid Stenting Decision Making Analysis To Overcome Challenges

Micromesh technology in carotid artery treatment what is next? Max Amor MD Clinique Louis Pasteur, Essey-Les-Nancy France

Carotid Artery Stenting

Carotid artery stents and embolic protection

Ostial Stents and Distal Embolic Protection During Renal Stenting

Extracranial Carotid Artery Stenting With or Without Distal Protection Device

Update on Carotid Stenting. John R. Laird Cardiovascular Research Institute Washington Hospital Center

New concepts for filter protection during CAS: double filtration. Alberto Cremonesi MD, FESC

CAROTID ARTERY ANGIOPLASTY

Future Perspectives of Micromesh Stents Antonio Micari MD Director Cardiovascular Units GVM Care and Research (Palermo, Italy)

PrOspective multicenter study of carotid artery stenting Usinng mer Stent OCEANUS study!!!

Evaluation of a new micromesh carotid stent with Optical Coherence Tomography.

Carotid artery percutaneous treatment: back to the future Alberto Cremonesi MD, FESC

Limitations of Other Embolic Protection Devices - Filters. Carotid Stenting with Flow Reversal. Limitations of Distal Occlusion

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service

Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis

Carotid. The. Issue. Now approved by the FDA, carotid stenting moves into the spotlight in endovascular care.

Mechanical Thrombectomy of Large Vessel Occlusions Using Stent Retriever Devices

5F Devices with 0.035

Carotid Artery Stenting (CAS) Pathophysiology. Technical Considerations. Plaque characteristics: relevant concepts. CAS and CEA

William A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, PA USA

Algorithm and Tools for the Uncrossable CTO

Embolic Protection Systems

SCAI Fall Fellows Course Subclavian/Innominate Case Presentation

Wael Tawfick Sherif Sultan UCHG, NUIG, RCSI

Algorithmic selection of emboli protection device during the procedure of carotid artery stunting

Is there a role for embolic protection during treatment of critical limb ischemia?

Carotid artery stenting in the elderly: the time has come

New Stroke Interventions. Scott L. Zuckerman M.D. Vanderbilt Neurosurgery

SCAFFOLD Study Gore PTFE mesh-covered stent preclinical and clinical data so far. Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii

Chronic Total Occlusion (CTO) Technologies

CTO: Technique and Tools

Carotid Revascularization 20 Years From Now

The grey zone of coronary interventions: Degenerated saphenous vein grafts

Tips and Tricks for CAS T-CAR

Managing Carotid Access from Straight - Forward to Complex Bernhard Reimers Cardiology Dept. Mirano Italy

Balloon-expandable closed-cell stents were introduced

Introducing the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System

My personal experience with INCRAFT in standard and challenging cases

Tailored carotid artery stenting

Multicenter Evaluation of Carotid Artery Stenting With a Filter Protection System

Koen Keirse, MD RZ Tienen, Belgium

The Spectrum of Dedicated Stents for Bifurcation Lesions: Current Status and Future Projections. Martin B. Leon, MD

STROKE PREVENTION IN AORTIC ARCH PROCEDURES

Avoiding and Managing Complications During CAS: Lessons Learned

Appropriate Device Selection for Endovascular Procedures

Chronic Total Occlusion (CTO) Technologies. Re-open vital channels

Copyright HMP Communications

Role of Distal Protection in Percutaneous Renal Intervention for Atherosclerotic Renovascular Disease

Zenith Alpha T HORACIC ENDOVASCULAR GRAFT

Bifurcated system Proximal suprarenal stent Modular (aortic main body and two iliac legs) Full thickness woven polyester graft material Fully

Antegrade techniques for CTO recanalization. Dr. George Karavolias, MD, PhD, FESC, FACC Interventional Cardiologist

Roadsaver the paradigm shift in carotid artery treatment. G. Torsello Münster

Solitaire FR Revascularization Device

Cordis ExoSeal. Maximise Clinical Safety*. The novel approach to secure and easy closure. Vascular Closure Device CORDIS EXOSEAL VCD

CoreValve Evolut R Technology review and Clinical Results. Paul TL Chiam

Assessment of the procedural etiology of stroke resulting from carotid artery stenting

Sentinel Dual Filter Device: Technology Overview and Status of the CLEAN-TAVI Randomized Trial. Martin B. Leon, MD

New Trials in Progress: ACT 1. Jon Matsumura, MD Cannes, France June 28, 2008

Balloon Expandable Covered Stents. Suddenly a Crowded Space

Will Mesh-covered Stents Help Reduce the Risk of Stroke? Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii

Pre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease

Maximise Clinical Safety*. Cordis ExoSeal. The novel approach to secure and easy closure. Vascular Closure Device CORDIS EXOSEAL VCD

Why I do not believe the

Penumbra INTRACRANIAL ACCESS REDEFINED

FRANK J. VEITH MAC TH MUNICH VASCULAR CONF

When and how to use distal protection devices for lower extremity revascularization. Peter A. Schneider, MD Kaiser Foundation Hospital, Honolulu

INCRAFT system: Update from the Pivotal INSPIRATION Study

TAVR in Intermediate Risk Populations /Optimizing Systems for TAVR

Embolization of atherothrombotic debris occurs commonly

Review of clinical carotid stent procedural & long-term outcomes in. symptomatic asymptomatic. patients

Malperfusion Syndromes Type B Aortic Dissection with Malperfusion

CASE REPORTS: Filters to Prevent Distal Embolization during Coronary Artery Stenting: The Risk of Mousetrap

Assurant Cobalt Iliac BALLOON EXPANDABLE STENT SYSTEM

Peter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI

Carotid Artery Stenting for Stroke Prevention Jacqueline Saw, MD

Cook Medical. Zenith Flex AAA Endovascular Graft with Z-Trak Introduction System Physician Training

proximal protection with the MO.ma device during carotid stenting

Renal Artery Stenting With Embolic Protection

SURPASS FLOW DIVERTER

Guidewire Selection. Making the Most Out of My Guidewire: LINC 2016: Leipzig Interventional Course Leipzig, Germany January 26-29, 2016

Non Atheromatous Lesions Fibromuscular Dysplasia. Rod Samuelson, MD Babak Jahromi,, MD Elad Levy, MD Adnan Siddiqui,, PhD, MD Nick Hopkins, MD

Strategies for PCI of SVG

DESPITE CURRENT LEVEL 1 EVIDENCE THE OUTLOOK FOR AN UPSURGE IN CAROTID STENTING (CAS) IS BRIGHT FRANK J. VEITH LINC LEIPZIG JANUARY 27, 2015

Contemporary Management of Carotid Disease What We Know So Far

Catheter selection for transradial angiography and intervention

THE THE MORE MORE NATURAL APPROACH TO OPTIMAL FIT

Transcription:

How to Choose Among Carotid Embolic Protection Devices? James P. Zidar, M.D., F.A.C.C., F.S.C.A.I. Associate Professor of Medicine Duke University Medical Center Director, Cardiovascular Services Duke Health Raleigh Hospital

Conflicts / Disclosures Consultant/Advisory Board member/research support: - Abbott Vascular - Cordis - Medtronic

Carotid Stenting: Intracranial Complications Distal Embolization- TIA, CVA Most are embolic, cannot be identified by angiography Some are due to air emboli (preventable!) Probably more common in symptomatic patients Can occur with CEA restenosis Causes Guiding catheter or sheath placement Incomplete embolic protection Most common cause of stroke with stenting

Cerebral embolism Patient selection is crucial as stroke is most common in: Age > 80 Complex anatomy of aortic arch, carotid artery Severe proximal or distal tortuousity Vessel and/or lesion calcification Thrombotic lesions String-sign Failure of the embolic protection device

Global Carotid Artery Stent Registry (GCASR): 30-Day Death/ All CVA * % 9 8 7 6 5 4 3 2 1 0 5.7 4 5.3 4.9 2.9 1997 2002 + Sxs 2.2 Sxs - DEP +DEP *Wholey M et al. TCT 2003; n>12,000

Devices for Distal Protection Balloon Occlusion Devices PercuSurge GuardWire ** TriActiv System Catheter Occlusion Devices Parodi Guiding KJ Coppi Invatec Guiding KT Kachel catheter VelociMed ** FDA-approved (carotid and SVG) Filter Devices Cordis Angioguard** Abbott/Guidant Accunet** BSC EPI Filterwire EZ ** Medtronic Interceptor Abbott Mednova** Microvena TRAP EV3 Spider**

PercuSurge GuardWire System Components: GuardWire EZ-Flator MicroSeal Adapter Export catheter

Pro s and Con s versus other systems Advantages Complete occlusion Proven effect in SVG s Flexible, low-profile stent delivery system Crosses most lesions Small parking space Disadvantages Complete occlusion Exludes pts with contralateral lesions Failure may cause stroke Speed is important OTW design

Distal Protection with Proximal Occlusion: Proxis System Distal Sealing Balloon * Protection During Initial Wire Crossing * Protection During Device Placement * * Evacuation sheath Vessel Evacuation

Proximal Occlusion Devices* Advantages Disadvantages Transient reversal of flow in distal More cumbersome to use than other artery devices; large profile Operator can select a guidewire of choice Imaging via stagnant contrast during device advancement Avoids embolization during initial Intermittent vessel occlusion passage of guidewire and throughout procedure * Velocimed Proxis studied in SVGs-PROXIMAL Trial

More EPDs/ Filters Dominate Scion BSX/Rubicon MedNova MDT/Interceptor Guidant AccuNet BSX/FilterWire Gen I MDT/PercuSurge BSX/FilterWire Gen II Abbot/Rubicon - Guardian MicroVena - Trap Kensey Nash

Distal Protection with Filter Devices Advantages Disadvantages Preserve antegrade flow May not capture all debris Contrast imaging is possible Difficult to evaluate retrieval of debris throughout the procedure Spider device allows operator to select a guidewire to cross target lesion during the procedure Filters may clog Delivery/retrieval catheters may cause embolization Fair support/steerability/profile

CAS - Distal Protection Devices FilterWire EX 80-110µ pore size ACCUNET 150 µ pore size AngioGuard XP 100µ pore size EV3 Spider 167-209µ pore size Abbott Emboshield 140 µ pore size

Rx Accunet DPFDesigned for Capture Efficiency Deployment in Tortuosity 7.5 mm RX ACCUNET 12 mm Designed to protect in challenging anatomy Dual strut filter configuration Flexible distal obturator Concentric filter design with guide wire centered in filter 4 radiopaque markers to visualize wall apposition Capture Capabilities Designed to capture a large embolic load 4.5, 5.5, 6.5, and 7.5 cm sizes

Peelable Delivery Sheath Controlled Delivery and Deployment Enter body as a single unit Exit as a rapid exchange catheter Helps stabilize ACCUNETTM Filter during unsheathing Partial Slit Faster exchanges Delivery sheath is peeled away during deployment

RX ACCUNET 2 Recovery Catheter Dedicated catheter for filter recovery 141 cm working length Rapid exchange (RX) design 0.014 guide wire compatible Radiopaque tip Soft, lower profile, flexible tip (ID=.038 ) to allow for deflection during advancement Flexible catheter shaft optimized for challenging GC/sheath access Catheter shaft markers: 95 cm, 105 cm

Rx Accunet DPF Carotid lesion prior to treatment Retrieval of RX ACCUNET RX ACCUNET with captured material

Abbott EmboShield Gen V 2.9-3.2 Fr Independent wire access ( 4 wires) 3.7-3.9F 140µ

Cordis ANGIOGUARD XP Emboli Capture Guidewire Polyurethane filter on a Nitinol frame Basket Diameter: 4-8 mm Oversize basket : 0.5 1.5 mm vs. RVD Filter Pore Size: 100 microns Crossing Profile: 3.5F Wire Diameter: 0.014

BEACH Boston Scientific EPI: A Carotid Stenting Trial for HighRisk Surgical Patients FilterWire EX Carotid Wallstent Monorail

The Filterwire EZ 3.2 French Crossing Profile 4.3 French Retrieval Catheter 110 µm Pore Size

Distal Embolic Protection Filters Spider Co FW EZ A-guard Accunet Embosh Intercep ev3 BSC CJJ GDT ABT MDT Material N N, PU N, PU N, PU N, PU N GW (in) 18 14 14 14 18 14 Rx Yes Yes Yes Yes Yes No Ind wire Yes No No No Yes No 6 6 6 6 6 7 Size (mm) 4-7 3.5-5.5 4-8 4.5-7.5 3-6 5.5-6.5 Profile (Fr) 3.2 3.2 3.2-3.9 3.5-3.7 3.7-3.9 2.9 167-209 110 100 120 140 100 Sheath (Fr) Pores (u)

How Can Distal Protection Fail? Inability to deliver device Profile, steerability, landing zone Device induced complications Vessel injury, distal embolization Procedural ischemia or intolerance Incomplete capture or retrieval of debris By device design (filter vs. balloon occlusion) Overwhelming burden of debris Embolization into proximal branches External carotid (Ophthalmic artery) Preventable with catheter-occlusion devices

Filter Features Delivery profile and flexibility Steerability Vessel wall apposition Pore size In vitro capture efficiency Ease of retrieval Clinical event rates

Distal Protection Advances Lower profile- 7Fr-> 4Fr -> 2.5 Fr Improved centering Improved transitions Independent wire movement EmboShield, Spider Independent wire use

Filters: Newer Devices Emboshield FilterWire EZ Interceptor Rubicon FiberNet

FiberNet Embolic Protection System Vessel conforming 3-dimensional fiber filter Particulate capture as low as 40 microns while maintaining blood flow during the procedure Filter mounted on.014 guidewire No delivery sheath required Low crossing profile (1.7-3.1F) Retrieval catheter with focal-suction during device removal Filter sizes to cover vessel diameters from 1.757.0mm Epic US Carotid Study: High surgical risk, multicenter, single arm registry, 30 day follow-up Epic European Carotid Study: Multicenter, single arm registry, 30 day followup

Carotid EPDs Filters should be the default mode Accunet, Angioguard and BSC Filterwire are all workhorse devices Abbott Emboshield and EV3 Spider offer the ability to wire independent of filter may be especially helpful with tortuosity and high grade lesions, reduces need for buddy wire Percusurge has a limited EPD role as the filter technology improves and nano-sizes Careful case selection, thoughtful preparation and execution are the keys to minimizing complications